Ambea
Market Cap
kr3.9b
Last Updated
2020/04/03 22:34 UTC
Data Sources
Company Financials +
Executive Summary
Ambea AB (publ), through its subsidiaries, primarily provides residential care services for people with disabilities and elderly care in Sweden and Norway.
Rewards
Risk Analysis
+ 2 more risks
Snowflake Analysis
Undervalued with reasonable growth potential.
Similar Companies
Share Price & News
How has Ambea's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AMBEA's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
-1.8%
AMBEA
-0.6%
SE Healthcare
0.3%
SE Market
1 Year Return
-46.3%
AMBEA
-19.2%
SE Healthcare
-13.2%
SE Market
Return vs Industry: AMBEA underperformed the Swedish Healthcare industry which returned -19% over the past year.
Return vs Market: AMBEA underperformed the Swedish Market which returned -12.2% over the past year.
Shareholder returns
| AMBEA | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.8% | -0.6% | 0.3% |
| 30 Day | -30.4% | -23.9% | -19.3% |
| 90 Day | -46.0% | -28.3% | -23.1% |
| 1 Year | -45.4%-46.3% | -18.3%-19.2% | -11.0%-13.2% |
| 3 Year | -46.6%-48.3% | -48.1%-50.0% | -0.2%-14.7% |
| 5 Year | n/a | 79.3%51.1% | 6.0%-16.1% |
Price Volatility Vs. Market
How volatile is Ambea's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Is It Too Late To Consider Buying Ambea AB (publ) (STO:AMBEA)?3 weeks ago | Simply Wall St
What Is Ambea's (STO:AMBEA) P/E Ratio After Its Share Price Tanked?4 weeks ago | Simply Wall St
If You Had Bought Ambea (STO:AMBEA) Stock A Year Ago, You'd Be Sitting On A 31% Loss, TodayValuation
Is Ambea undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AMBEA (SEK41.65) is trading below our estimate of fair value (SEK166.05)
Significantly Below Fair Value: AMBEA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AMBEA is good value based on its PE Ratio (16.6x) compared to the Healthcare industry average (17x).
PE vs Market: AMBEA is poor value based on its PE Ratio (16.6x) compared to the Swedish market (14.3x).
Price to Earnings Growth Ratio
PEG Ratio: AMBEA is good value based on its PEG Ratio (0.5x)
Price to Book Ratio
PB vs Industry: AMBEA is good value based on its PB Ratio (1x) compared to the SE Healthcare industry average (1.2x).
Next Steps
Future Growth
How is Ambea forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
32.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMBEA's forecast earnings growth (32.6% per year) is above the savings rate (-0.4%).
Earnings vs Market: AMBEA's earnings (32.6% per year) are forecast to grow faster than the Swedish market (8% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMBEA's revenue (6.7% per year) is forecast to grow faster than the Swedish market (4.1% per year).
High Growth Revenue: AMBEA's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMBEA's Return on Equity is forecast to be low in 3 years time (13.9%).
Next Steps
Past Performance
How has Ambea performed over the past 5 years?
25.4%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AMBEA has a large one-off loss of SEK137.0M impacting its December 31 2019 financial results.
Growing Profit Margin: AMBEA's current net profit margins (1.9%) are lower than last year (4.9%).
Past Earnings Growth Analysis
Earnings Trend: AMBEA's earnings have grown significantly by 25.4% per year over the past 5 years.
Accelerating Growth: AMBEA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMBEA had negative earnings growth (-27.1%) over the past year, making it difficult to compare to the Healthcare industry average (-25.3%).
Return on Equity
High ROE: AMBEA's Return on Equity (5.3%) is considered low.
Next Steps
Financial Health
How is Ambea's financial position?
Financial Position Analysis
Short Term Liabilities: AMBEA's short term assets (SEK1.5B) do not cover its short term liabilities (SEK4.4B).
Long Term Liabilities: AMBEA's short term assets (SEK1.5B) do not cover its long term liabilities (SEK5.4B).
Debt to Equity History and Analysis
Debt Level: AMBEA's debt to equity ratio (79%) is considered high.
Reducing Debt: AMBEA's debt to equity ratio has increased from 44.6% to 79% over the past 5 years.
Debt Coverage: AMBEA's debt is well covered by operating cash flow (30.8%).
Interest Coverage: AMBEA's interest payments on its debt are not well covered by EBIT (2.7x coverage).
Balance Sheet
Inventory Level: AMBEA has a high level of physical assets or inventory.
Debt Coverage by Assets: AMBEA's debt is not covered by short term assets (assets are 0.5x debt).
Next Steps
Dividend
What is Ambea's current dividend yield, its reliability and sustainability?
3.86%
Forecast Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AMBEA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate AMBEA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AMBEA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AMBEA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: AMBEA is not paying a notable dividend for the Swedish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMBEA's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.3yrs
Average management tenure
CEO
Fredrik Gren (51yo)
8.17s
Tenure
kr9,141,257
Compensation
Mr. Fredrik Gren serves as the Chief Executive Officer and President of Ambea AB (Ambea) at Carema Care AB since February 1, 2012. Mr. Gren served as President of Ambea AB. He served as the Chief Executive ...
CEO Compensation Analysis
Compensation vs Market: Fredrik's total compensation ($USD898.07K) is above average for companies of similar size in the Swedish market ($USD650.81K).
Compensation vs Earnings: Fredrik's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & President | 8.17yrs | kr9.14m | 0.33% SEK12.9m | |
| Deputy CEO & CFO | 9.25yrs | no data | 0.47% SEK18.6m | |
| Head of Group Business Control & Investor Relations | 1.83yrs | no data | no data | |
| Director of Human Resources | no data | no data | no data | |
| Temporary Head of Nytida | 3.33yrs | no data | no data | |
| Business Area Head of Vardaga | 7.25yrs | no data | 0.39% SEK15.4m | |
| Head of Quality | no data | no data | no data | |
| Business Area Manager of Nytida | 2.25yrs | no data | 0.023% SEK891.3k | |
| Business Area Manager of Altiden | 1.25yrs | no data | 0.0021% SEK83.4k | |
| Business Area Manager of Stendi | no data | no data | no data |
3.3yrs
Average Tenure
58yo
Average Age
Experienced Management: AMBEA's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 1.92yrs | kr175.52k | 0.0032% SEK125.1k | |
| Independent Director | 0.92yr | no data | no data | |
| Independent Director | 3.67yrs | kr400.00k | 0.014% SEK555.4k | |
| Director | 1.92yrs | kr175.52k | no data | |
| Director | 6.25yrs | kr365.00k | no data | |
| Chairperson | 7.25yrs | kr905.67k | 0.62% SEK24.2m | |
| Director | 0.92yr | kr133.21k | no data | |
| Employee Representative Director | 4.25yrs | no data | no data | |
| Employee Representative Director | 4.25yrs | no data | no data | |
| Employee Representative Director | 4.25yrs | no data | no data |
4.0yrs
Average Tenure
60yo
Average Age
Experienced Board: AMBEA's board of directors are considered experienced (4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AMBEA insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.9%.
Top Shareholders
Company Information
Ambea AB (publ)'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Ambea AB (publ)
- Ticker: AMBEA
- Exchange: OM
- Founded: 1996
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: kr3.933b
- Shares outstanding: 94.44m
- Website: https://www.ambea.com
Number of Employees
Location
- Ambea AB (publ)
- Evenemangsgatan 21, 6 tr
- Box 1565
- Solna
- Stockholm County
- 171 29
- Sweden
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 0RNX | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | SEK | Mar 2017 |
| AMBEA | OM (OMX Nordic Exchange Stockholm) | Yes | Ordinary Shares | SE | SEK | Mar 2017 |
| AMBEAS | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | SEK | Mar 2017 |
| 6MA | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Mar 2017 |
Biography
Ambea AB (publ), through its subsidiaries, primarily provides residential care services for people with disabilities and elderly care in Sweden and Norway. The company operates through four segments: Vardaga, Nytida, Hemita, and Klara. It offers services for the long and short-term residential facilities for children and adults, and with special service and daily activities for adults with an autism diagnosis and intellectual disabilities; elderly care in the form of special housing; and support services in the form of HVB homes, assisted housing, family homes, outpatient care, special housing, and institutional care for children, young people, and adults and families under the Nytida brand, as well as special housing services for the elderly, such as older people, who are unable to remain in their own homes under the Vardaga brand; disability care services in the form of residential care, rehabilitation, respite, and assessment under the Heimta brand. The company also provides training and staffing solutions for municipalities, county councils, and private operators under the Klara brand; and works with the temporary supply and recruitment of doctors and nurses, as well as offers residential and outpatient psychiatric support, and residential facilities for people with lifelong disabilities under the Heimta brand. In addition, it offers ambulatory services. Ambea AB (publ) was founded in 1996 and is headquartered in Solna, Sweden.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/04/03 22:34 |
| End of Day Share Price | 2020/04/03 00:00 |
| Earnings | 2019/12/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.